Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR

Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR

Pregnane X receptor (PXR) which belongs to the nuclear hormone receptor superfamily plays vital roles in several biological functions, especially in the inflammatory procedure. Besides that, PXR is revealed by recent studies to have essential effects on bone tissue. As an agonist of PXR, meclizine i...

Full description

Bibliographic Details
Main Authors:	Jiachao Guo, Weijin Li, Yingxing Wu, Xingzhi Jing, Junming Huang, Jiaming Zhang, Wei Xiang, Ranyue Ren, Zhengtao Lv, Jun Xiao, Fengjing Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-10-01
Series:	Frontiers in Pharmacology
Subjects:	meclizine PXR osteoclast RANKL osteoporosis
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00693/full

Similar Items

Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
by: Jiachao Guo, et al.
Published: (2018-01-01)

Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent—Meclizine HCl
by: Faaiza Qazi, et al.
Published: (2017-04-01)

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018-09-01)

Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018-10-01)

Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Hui Liu, et al.
Published: (2021-03-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
by: Guoju Hong, et al.
Published: (2020-03-01)

(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
by: Hung-Bo Hsiao, et al.
Published: (2017-05-01)

A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
by: Zhi Xin, et al.
Published: (2018-01-01)

Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
by: Zhi Xin, et al.
Published: (2021-03-01)

Ethanol Extract of Atractylodes macrocephala Protects Bone Loss by Inhibiting Osteoclast Differentiation
by: Youn-Hwan Hwang, et al.
Published: (2013-06-01)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
by: Yunfei Zhan, et al.
Published: (2020-01-01)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
by: Qiang Xu, et al.
Published: (2021-06-01)

Regulation of CAR and PXR Expression in Health and Disease
by: Martine Daujat-Chavanieu, et al.
Published: (2020-10-01)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017-06-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Jia Wang, et al.
Published: (2020-07-01)

Patchouli Alcohol Modulates the Pregnancy X Receptor/Toll-like Receptor 4/Nuclear Factor Kappa B Axis to Suppress Osteoclastogenesis
by: Qian Lu, et al.
Published: (2021-06-01)

The Fungal Metabolite (+)-Terrein Abrogates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-κB Ligand–Induced Osteoclastogenesis by Suppressing Protein Kinase-C α/βII Phosphorylation
by: Kyosuke Sakaida, et al.
Published: (2021-06-01)

Oxymatrine Attenuates Osteoclastogenesis via Modulation of ROS-Mediated SREBP2 Signaling and Counteracts Ovariectomy-Induced Osteoporosis
by: Chao Jiang, et al.
Published: (2021-05-01)

NRF2 is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion
by: Peter Sang Uk Park, et al.
Published: (2020-09-01)

Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways
by: Kai Chen, et al.
Published: (2020-06-01)

Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis
by: Shu-jun Wei, et al.
Published: (2021-01-01)

A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
by: Guoju Hong, et al.
Published: (2021-05-01)

<i>Eleutherococcus sessiliflorus</i> Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
by: Sang-Yong Han, et al.
Published: (2021-03-01)

Adiponectin Deficiency Triggers Bone Loss by Up-Regulation of Osteoclastogenesis and Down-Regulation of Osteoblastogenesis
by: Jihyun Yang, et al.
Published: (2019-11-01)

Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
by: Aikaterini Skandalaki, et al.
Published: (2021-08-01)

Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling
by: Mi-Hwa Kim, et al.
Published: (2020-12-01)

Regulatory B Cells (Bregs) Inhibit Osteoclastogenesis and Play a Potential Role in Ameliorating Ovariectomy-Induced Bone Loss
by: Leena Sapra, et al.
Published: (2021-06-01)

Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2015-06-01)

Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
by: Cong Cai, et al.
Published: (2018-11-01)

Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling
by: Yoon-Hee Cheon, et al.
Published: (2020-09-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
by: Feng-Jen Tseng, et al.
Published: (2015-07-01)

Theaflavin-3, 3′-Digallate Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Ovariectomy-Induced Bone Loss in Mice
by: Zexin Ai, et al.
Published: (2020-06-01)

Pregnane X receptor (PXR)-mediated gene repression and cross-talk of PXR with other nuclear receptors via coactivator interactions
by: Petr Pavek
Published: (2016-11-01)

Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERα to inhibit RANKL signaling
by: Keqi Wang, et al.
Published: (2021-02-01)

Muscone Ameliorates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-κb Ligand-Induced Osteoclastogenesis by Suppressing TNF Receptor–Associated Factor 6-Mediated Signaling Pathways
by: Xiao Zhai, et al.
Published: (2020-03-01)

(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
by: Shih-Tse Chen, et al.
Published: (2019-01-01)

Anti-osteoporotic effects of alisol C 23-acetate via osteoclastogenesis inhibition
by: Xiaokang Jia, et al.
Published: (2021-05-01)

Chloroquine ameliorates bone loss induced by d-galactose in male rats via inhibition of ERK associated osteoclastogenesis and antioxidant effect
by: Mohamed A. Aziz Mahmoud, et al.
Published: (2021-01-01)